Publication

Traumatic Brain Injury: Nuclear Medicine Neuroimaging

Sánchez-Catasús, C. A., Vállez Garcia, D., Le Riverend Morales, E., Galvizu Sánchez, R. & Dierckx, R., 23-Apr-2014, PET and SPECT in Neurology. Dierckx, R. AJO., Otte, A., de Vries, E. FJ., van Waarde, A. & Leenders, K. L. (eds.). Springer, p. 923-946 45

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

APA

Sánchez-Catasús, C. A., Vállez Garcia, D., Le Riverend Morales, E., Galvizu Sánchez, R., & Dierckx, R. (2014). Traumatic Brain Injury: Nuclear Medicine Neuroimaging. In R. AJO. Dierckx, A. Otte, E. FJ. de Vries, A. van Waarde, & K. L. Leenders (Eds.), PET and SPECT in Neurology (pp. 923-946). [45] Springer. https://doi.org/10.1007/978-3-642-54307-4_45

Author

Sánchez-Catasús, Carlos A ; Vállez Garcia, David ; Le Riverend Morales, Eloísa ; Galvizu Sánchez, Reinaldo ; Dierckx, Rudi. / Traumatic Brain Injury: Nuclear Medicine Neuroimaging. PET and SPECT in Neurology. editor / Rudi AJO Dierckx ; Andreas Otte ; Erik FJ de Vries ; Aren van Waarde ; Klaus L Leenders. Springer, 2014. pp. 923-946

Harvard

Sánchez-Catasús, CA, Vállez Garcia, D, Le Riverend Morales, E, Galvizu Sánchez, R & Dierckx, R 2014, Traumatic Brain Injury: Nuclear Medicine Neuroimaging. in RAJO Dierckx, A Otte, EFJ de Vries, A van Waarde & KL Leenders (eds), PET and SPECT in Neurology., 45, Springer, pp. 923-946. https://doi.org/10.1007/978-3-642-54307-4_45

Standard

Traumatic Brain Injury: Nuclear Medicine Neuroimaging. / Sánchez-Catasús, Carlos A; Vállez Garcia, David; Le Riverend Morales, Eloísa; Galvizu Sánchez, Reinaldo; Dierckx, Rudi.

PET and SPECT in Neurology. ed. / Rudi AJO Dierckx; Andreas Otte; Erik FJ de Vries; Aren van Waarde; Klaus L Leenders. Springer, 2014. p. 923-946 45.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Vancouver

Sánchez-Catasús CA, Vállez Garcia D, Le Riverend Morales E, Galvizu Sánchez R, Dierckx R. Traumatic Brain Injury: Nuclear Medicine Neuroimaging. In Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL, editors, PET and SPECT in Neurology. Springer. 2014. p. 923-946. 45 https://doi.org/10.1007/978-3-642-54307-4_45


BibTeX

@inbook{b2b8a65abdb347489d27464b4fc54bd3,
title = "Traumatic Brain Injury: Nuclear Medicine Neuroimaging",
abstract = "This chapter provides an up-to-date review of nuclear medicine neuroimaging in traumatic brain injury (TBI). 18F-FDG PET will remain a valuable tool in researching complex mechanisms associated with early metabolic dysfunction in TBI. Although evidence-based imaging studies are needed, 18F-FDG PET in the TBI acute phase appeared to be more useful in those patients in whom structural neuroimages fail to show abnormalities explaining their neurological state. 15O2-PET is also a solid technique for research in acute TBI, but in contrast to 18F-FDG PET it is not widely available due to its high cost. In the chronic TBI phase, most 18F-FDG PET studies converge to identify a diffuse cortical–subcortical hypometabolism involving key regions for cognitive function. Recent studies suggest the usefulness of 18F-FDG PET for the evaluation of therapeutic interventions in chronic TBI patients with cognitive deficits. In recent years, interest in studying cell-specific processes is growing. The use of radioligands as markers of neuroinflammation could become attractive for detecting secondary damage and serve for the evaluation of different therapeutic approaches. SPECT advances also make this technique a valid alternative for the study of TBI.",
author = "S{\'a}nchez-Catas{\'u}s, {Carlos A} and {V{\'a}llez Garcia}, David and {Le Riverend Morales}, Eloísa and {Galvizu Sánchez}, Reinaldo and Rudi Dierckx",
year = "2014",
month = "4",
day = "23",
doi = "10.1007/978-3-642-54307-4_45",
language = "English",
isbn = "978-3-642-54306-7",
pages = "923--946",
editor = "Dierckx, {Rudi AJO} and Andreas Otte and {de Vries}, {Erik FJ} and {van Waarde}, Aren and Leenders, {Klaus L}",
booktitle = "PET and SPECT in Neurology",
publisher = "Springer",

}

RIS

TY - CHAP

T1 - Traumatic Brain Injury: Nuclear Medicine Neuroimaging

AU - Sánchez-Catasús, Carlos A

AU - Vállez Garcia, David

AU - Le Riverend Morales, Eloísa

AU - Galvizu Sánchez, Reinaldo

AU - Dierckx, Rudi

PY - 2014/4/23

Y1 - 2014/4/23

N2 - This chapter provides an up-to-date review of nuclear medicine neuroimaging in traumatic brain injury (TBI). 18F-FDG PET will remain a valuable tool in researching complex mechanisms associated with early metabolic dysfunction in TBI. Although evidence-based imaging studies are needed, 18F-FDG PET in the TBI acute phase appeared to be more useful in those patients in whom structural neuroimages fail to show abnormalities explaining their neurological state. 15O2-PET is also a solid technique for research in acute TBI, but in contrast to 18F-FDG PET it is not widely available due to its high cost. In the chronic TBI phase, most 18F-FDG PET studies converge to identify a diffuse cortical–subcortical hypometabolism involving key regions for cognitive function. Recent studies suggest the usefulness of 18F-FDG PET for the evaluation of therapeutic interventions in chronic TBI patients with cognitive deficits. In recent years, interest in studying cell-specific processes is growing. The use of radioligands as markers of neuroinflammation could become attractive for detecting secondary damage and serve for the evaluation of different therapeutic approaches. SPECT advances also make this technique a valid alternative for the study of TBI.

AB - This chapter provides an up-to-date review of nuclear medicine neuroimaging in traumatic brain injury (TBI). 18F-FDG PET will remain a valuable tool in researching complex mechanisms associated with early metabolic dysfunction in TBI. Although evidence-based imaging studies are needed, 18F-FDG PET in the TBI acute phase appeared to be more useful in those patients in whom structural neuroimages fail to show abnormalities explaining their neurological state. 15O2-PET is also a solid technique for research in acute TBI, but in contrast to 18F-FDG PET it is not widely available due to its high cost. In the chronic TBI phase, most 18F-FDG PET studies converge to identify a diffuse cortical–subcortical hypometabolism involving key regions for cognitive function. Recent studies suggest the usefulness of 18F-FDG PET for the evaluation of therapeutic interventions in chronic TBI patients with cognitive deficits. In recent years, interest in studying cell-specific processes is growing. The use of radioligands as markers of neuroinflammation could become attractive for detecting secondary damage and serve for the evaluation of different therapeutic approaches. SPECT advances also make this technique a valid alternative for the study of TBI.

U2 - 10.1007/978-3-642-54307-4_45

DO - 10.1007/978-3-642-54307-4_45

M3 - Chapter

SN - 978-3-642-54306-7

SP - 923

EP - 946

BT - PET and SPECT in Neurology

A2 - Dierckx, Rudi AJO

A2 - Otte, Andreas

A2 - de Vries, Erik FJ

A2 - van Waarde, Aren

A2 - Leenders, Klaus L

PB - Springer

ER -

ID: 16217408